Prediction of the binding mode between GSK3β and a peptide derived from GSKIP using molecular dynamics simulation

Insights in 17β-HSD1 Enzyme Kinetics and Ligand Binding by Dynamic Motion Investigation

(2010) Matthias Negri et al.   PLoS One

Some insights into mechanism for binding and drug resistance of wild type and I50V V82A and I84V mutations in HIV-1 protease with GRL-98065 inhibitor from molecular dynamic simulations

(2009) Guo-Dong Hu et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

GSKIP, an inhibitor of GSK3β, mediates the N-cadherin/β-catenin pool in the differentiation of SH-SY5Y cells

(2009) Ching-Chih Lin et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Insights into drug resistance of mutations D30N and I50V to HIV-1 protease inhibitor TMC-114: Free energy calculation and molecular dynamic simulation

(2009) Jianzhong Chen et al.   JOURNAL OF MOLECULAR MODELING

Involvement of the residues of GSKIP, AxinGID, and FRATtide in their binding with GSK3β to unravel a novel C-terminal scaffold-binding region

(2009) Shen-Long Howng et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Olanzapine inhibits glycogen synthase kinase-3β: An investigation by docking simulation and experimental validation

(2008) Mohammad K. Mohammad et al.   EUROPEAN JOURNAL OF PHARMACOLOGY